Stay updated with breaking news from Nasdaq Seel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 808,800 shares, a drop of 91.6% from the November 15th total of 9,650,000 shares. Based on an average daily volume of 562,700 shares, the short-interest ratio […]
Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report)’s stock price shot up 8.3% during mid-day trading on Tuesday . The company traded as high as $0.21 and last traded at $0.20. 9,790,128 shares traded hands during trading, an increase of 447% from the average session volume of 1,789,619 shares. The stock had previously closed at […]
Cantor Fitzgerald reiterated their overweight rating on shares of Seelos Therapeutics (NASDAQ:SEEL – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently have a $2.00 target price on the stock. Separately, BTIG Research decreased their target price on Seelos Therapeutics from $11.00 to $4.00 in a research note on Monday, […]
Seelos Therapeutics (NASDAQ:SEEL – Get Rating) had its price objective dropped by investment analysts at Cantor Fitzgerald from $3.00 to $2.00 in a report issued on Tuesday, The Fly reports. Cantor Fitzgerald’s price objective suggests a potential upside of 100.00% from the company’s current price. Other analysts also recently issued reports about the stock. Benchmark […]
Modera Wealth Management LLC purchased a new position in shares of Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm purchased 871,505 shares of the company’s stock, valued at approximately $592,000. Several other institutional investors and hedge funds have also made changes to their positions in the business. […]